Payment overview · 2025
General Payments
82 reported records · 14 companies
Healthcare provider profile · identity verified
Dental Providers|Dentist|General Practice · COLMAR, PA · NPI 1124033774
Verified facts
CMS Open Payments records show Dilip N Dudhat, DMD received $9,284.02 in general payments during 2025 across 82 reported records.
A-dec, Inc. accounted for 32.8% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 17 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Payment overview · 2025
82 reported records · 14 companies
Separate record types
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| A-dec, Inc. | Unresolved — no canonical attribution shown | $3,042.50 | 32.8% | 9 | 2025 |
| Straumann USA LLC | Unresolved — no canonical attribution shown | $2,657.13 | 28.6% | 37 | 2025 |
| PureLife, LLC | Unresolved — no canonical attribution shown | $1,270.00 | 13.7% | 9 | 2025 |
| Dentsply Sirona Inc | Unresolved — no canonical attribution shown | $798.86 | 8.6% | 6 | 2025 |
| Envista Holdings Corporation | Unresolved — no canonical attribution shown | $414.92 | 4.5% | 8 | 2025 |
| Hu-Friedy Mfg. Co., LLC | Unresolved — no canonical attribution shown | $378.24 | 4.1% | 3 | 2025 |
| Premier Dental Products Company | Unresolved — no canonical attribution shown | $225.00 | 2.4% | 1 | 2025 |
| Henry Schein, Inc. | Unresolved — no canonical attribution shown | $133.80 | 1.4% | 1 | 2025 |
| Align Technology, Inc. | Unresolved — no canonical attribution shown | $121.76 | 1.3% | 1 | 2025 |
| Benco Dental Supply Co. | Unresolved — no canonical attribution shown | $70.11 | 0.8% | 1 | 2025 |
| Maillefer Instruments Holding Sarl | Unresolved — no canonical attribution shown | $60.00 | 0.7% | 1 | 2025 |
| OraPharma, a division of Bausch Health US, LLC | Unresolved — no canonical attribution shown | $54.45 | 0.6% | 3 | 2025 |
| VOCO America Inc. | Unresolved — no canonical attribution shown | $44.47 | 0.5% | 1 | 2025 |
| Kettenbach LP | Unresolved — no canonical attribution shown | $12.78 | 0.1% | 1 | 2025 |
What were the payments for?
| Category | Amount | Records |
|---|---|---|
| Gift | $4,392.18 | 20 |
| Food and Beverage | $3,306.07 | 49 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $790.00 | 5 |
| Education | $440.08 | 4 |
| Honoraria | $295.11 | 2 |
| Entertainment | $60.58 | 2 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Palodent Plus EZ Coat Sectional Matrix System Normalized: palodent plus ez coat sectional matrix system |
Device | Dentsply Sirona Inc | $600.00 | 1 | 2025 |
Source payment records
|
|||||
| SPARK Normalized: spark |
Device | Envista Holdings Corporation | $308.26 | 6 | 2025 |
Source payment records
|
|||||
| IMS Normalized: ims |
Device | Hu-Friedy Mfg. Co., LLC | $277.03 | 1 | 2025 |
Source payment records
|
|||||
| Enamelon Gel Normalized: enamelon gel |
Biological | Premier Dental Products Company | $225.00 | 1 | 2025 |
Source payment records
|
|||||
| Enamelon Toothpaste Normalized: enamelon toothpaste |
Biological | Premier Dental Products Company | $225.00 | 1 | 2025 |
Source payment records
|
|||||
| Two Striper Normalized: two striper |
Biological | Premier Dental Products Company | $225.00 | 1 | 2025 |
Source payment records
|
|||||
| Invisalign Normalized: invisalign |
Device | Align Technology, Inc. | $121.76 | 1 | 2025 |
Source payment records
|
|||||
| ZIRCONIA ABUTMENT PREPARATION KIT Normalized: zirconia abutment preparation kit |
Device | Envista Holdings Corporation | $61.84 | 1 | 2025 |
Source payment records
|
|||||
| Sani-Tab Chain-Free Econoback Towels Normalized: sani tab chain free econoback towels |
Device | Hu-Friedy Mfg. Co., LLC | $61.21 | 1 | 2025 |
Source payment records
|
|||||
| WaveOne Gold Conform Fit Normalized: waveone gold conform fit |
Device | Maillefer Instruments Holding Sarl | $60.00 | 1 | 2025 |
Source payment records
|
|||||
| ARESTIN Normalized: arestin |
Drug | OraPharma, a division of Bausch Health US, LLC | $54.45 | 3 | 2025 |
Source payment records
|
|||||
| Midwest E Plus Normalized: midwest e plus |
Device | Dentsply Sirona Inc | $50.09 | 1 | 2025 |
Source payment records
|
|||||
| TF ADAPTIVE Normalized: tf adaptive |
Device | Envista Holdings Corporation | $44.82 | 1 | 2025 |
Source payment records
|
|||||
| Admira Fusion x-tra Normalized: admira fusion x tra |
Device | VOCO America Inc. | $44.47 | 1 | 2025 |
Source payment records
|
|||||
| Futurabond U Normalized: futurabond u |
Device | VOCO America Inc. | $44.47 | 1 | 2025 |
Source payment records
|
|||||
| Meron Plus QM Normalized: meron plus qm |
Device | VOCO America Inc. | $44.47 | 1 | 2025 |
Source payment records
|
|||||
| MIS Normalized: mis |
Device | Dentsply Sirona Inc | $18.77 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Amoxicillin | Amoxicillin | 124 | 109 |
Timeline
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $9,284.02 · 82 records | A-dec, Inc. | ARESTIN, Admira Fusion x-tra, Enamelon Gel, Enamelon Toothpaste, Futurabond U, IMS, Invisalign, MIS, Meron Plus QM, Midwest E Plus, Palodent Plus EZ Coat Sectional Matrix System, SPARK, Sani-Tab Chain-Free Econoback Towels, TF ADAPTIVE, Two Striper, WaveOne Gold Conform Fit, ZIRCONIA ABUTMENT PREPARATION KIT | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error